Shared Risk Factors and Mechanisms in Cardiovascular Diseases and Cancer

Introduction

Cardiovascular diseases (CVD) and cancer are the two leading causes of mortality globally, jointly accounting for almost 40% of all deaths annually. While these conditions have traditionally been treated as distinct entities, increasing evidence highlights their shared risk factors and overlapping pathophysiological mechanisms. Key lifestyle behaviors, such as tobacco use, unhealthy diets, sedentary lifestyles, alcohol consumption, and poorly managed chronic conditions like diabetes mellitus – serve as significant contributors to the development and progression of both diseases. Age further amplifies these risks, acting as a universal non-modifiable determinant.

Understanding these shared and disease-specific risk factors is critical for developing effective prevention and management strategies. It also emphasizes the need for interdisciplinary collaboration between cardiology and oncology to address these intertwined health challenges. 

Aim of the Review

This brief review aims to analyze the shared and distinct risk factors for CVD and cancer, focusing on modifiable lifestyle behaviors and the non-modifiable influence of age. It synthesizes evidence from large-scale trials and international guidelines to propose unified prevention and management strategies while acknowledging disease-specific considerations.

Risk Factors

1. Tobacco Use

Tobacco use remains one of the most significant modifiable risk factors for both cardiovascular diseases and cancer.

Similarities:

1. Inflammation and Oxidative Stress: 

Tobacco smoke contains over 7,000 chemicals, many of which are toxic and carcinogenic. These substances induce systemic inflammation and oxidative stress, damaging endothelial cells in CVD and causing DNA mutations in cancer.

• Key Evidence: The World Health Organization (WHO) estimates that tobacco use contributes to 17% of all cardiovascular deaths and is responsible for approximately 22% of global cancer deaths.

2. Impact on Lipid Profiles: 

Smoking increases low-density lipoprotein (LDL) cholesterol while decreasing high-density lipoprotein (HDL) cholesterol, promoting atherogenesis in CVD. Simultaneously, it creates a pro-inflammatory environment that exacerbates cancer progression.

• Key Evidence: Studies published in The Lancet confirm that smoking-induced dyslipidemia is a critical factor in cardiovascular morbidity.

Differences:

• CVD: Nicotine accelerates atherosclerosis, promotes thrombogenesis, and impairs endothelial function, leading to acute cardiovascular events such as myocardial infarction and stroke.
• Cancer: Carcinogens in tobacco smoke, such as benzene and formaldehyde, cause genetic mutations, disrupt tumor suppressor genes, and stimulate tumor initiation and progression.

Key Evidence: The Journal of Clinical Oncology reports that prolonged tobacco exposure increases the risk of lung, bladder, and oral cancers by up to 25 times compared to non-smokers.

Guidelines and Recommendations:

• The WHO strongly recommends comprehensive tobacco cessation programs and public policies, such as smoking bans and increased taxes on tobacco products, to reduce both CVD and cancer risks.

2. Unhealthy Diet

An unhealthy diet is a major driver of metabolic dysfunction and chronic disease, influencing both CVD and cancer.

Similarities:

Pro-Inflammatory Effects: 

Diets high in saturated fats, refined sugars, and ultra-processed foods contribute to systemic inflammation, promoting both atherosclerosis and tumorigenesis.

• Key Evidence: The EPIC study (The Lancet, 2003) demonstrated that high dietary fiber intake is associated with reduced risks of colorectal cancer and cardiovascular diseases through reduced inflammation and improved lipid metabolism.

Obesity as a Mediator: 

Poor dietary habits are a leading cause of obesity, a shared risk factor for CVD and cancers such as breast, colorectal, and endometrial cancers. Obesity promotes insulin resistance and chronic low-grade inflammation, creating a favorable environment for both conditions.

• Key Evidence: The Nurses’ Health Study revealed that individuals with a BMI ≥30 had a 1.5-fold higher risk of developing CVD and certain cancers compared to those with a normal BMI.

Differences:

• CVD: Diets high in sodium directly contribute to hypertension, increasing the risk of heart attacks and strokes.
• Cancer: Processed and red meats are closely linked to colorectal cancer due to the production of carcinogenic compounds during processing and cooking.

Key Evidence: The INTERSALT study (BMJ, 1988) confirmed the detrimental effects of sodium on blood pressure, while the EPIC study identified red meat as a significant risk factor for colorectal cancer.

3. Physical Inactivity

A sedentary lifestyle is a well-established risk factor for chronic diseases, including CVD and cancer.

Similarities:

1. Inflammation and Metabolic Dysfunction: 

Physical inactivity exacerbates insulin resistance, obesity, and systemic inflammation, driving the pathophysiology of both CVD and cancer.

• Key Evidence: Research in JAMA Cardiology shows that prolonged sedentary time is associated with a 20–30% increased risk of cardiovascular and cancer-related mortality.

Differences:

• CVD: Sedentary behavior directly affects vascular health by increasing arterial stiffness and impairing endothelial function.
• Cancer: Inactivity alters hormone levels and immune function, increasing the risk of hormone-sensitive cancers such as breast and prostate cancers.

Key Evidence: The American Cancer Society links prolonged physical inactivity to a 25% higher risk of colon and endometrial cancers.

Guidelines and Recommendations:

• The ESC guidelines on cardio-oncology emphasize regular physical activity as a critical intervention to mitigate the cardiotoxic effects of cancer treatments.

4. Alcohol Consumption

Alcohol consumption impacts both diseases, albeit through distinct pathways.

Similarities:

Alcohol metabolism generates reactive oxygen species, leading to DNA damage in cancer and endothelial dysfunction in CVD.

• Key Evidence: WHO reports that alcohol consumption contributes to 10% of global cancer cases and is a significant contributor to hypertension and atrial fibrillation.

Differences:

• CVD: Light to moderate alcohol consumption may have limited cardio protective effects, but excessive intake increases risks of hypertension, cardiomyopathy, and arrhythmias.
• Cancer: Any level of alcohol consumption increases cancer risk, particularly for breast and liver cancers.

Key Evidence: The American Cancer Society highlights a linear relationship between alcohol intake and cancer risk.

5. Diabetes Mellitus

Diabetes significantly elevates the risk of both diseases through hyperglycemia, insulin resistance, and chronic inflammation.

Similarities:

Chronic hyperglycemia damages vascular endothelium in CVD and DNA in cancer cells. Elevated insulin levels promote cell proliferation, driving atherosclerosis and tumor growth.

 Differences:

• CVD: Diabetes accelerates atherosclerosis and platelet aggregation.  
• Cancer: Insulin-like growth factors (IGFs) stimulate tumor growth, particularly in colorectal and pancreatic cancers.  

Key Evidence: The UKPDS study shows that glycemic control reduces cardiovascular events, while its effect on cancer remains inconclusive.

6. Age as a Risk Factor

Age is a universal, non-modifiable risk factor that significantly amplifies susceptibility to both cardiovascular diseases (CVD) and cancer.

Similarities:

Aging contributes to cumulative exposure to risk factors such as smoking, poor diet, and physical inactivity. It also exacerbates systemic inflammation and oxidative stress, which are central drivers of atherosclerosis in CVD and tumorigenesis in cancer.

Key Evidence:

• The Global Burden of Disease Study 2019 revealed that over 80% of CVD-related deaths occur in individuals aged 65 and older, highlighting the cumulative impact of vascular aging and lifestyle risk factors.
• A large cohort study published in The Lancet Oncology demonstrated that individuals over 50 have a significantly higher risk of cancer incidence and mortality, with age-related immune dysregulation and genetic mutations being critical contributors.

Differences:

CVD: Advanced age is associated with vascular stiffening, reduced endothelial function, and impaired repair mechanisms, increasing the risk of acute events like myocardial infarction and stroke.

• Key Evidence: The Framingham Heart Study demonstrated that arterial stiffness, as measured by pulse wave velocity, is an independent predictor of cardiovascular events in older adults.

Cancer: Aging increases the accumulation of genetic mutations, cellular senescence, and chronic inflammation, all of which contribute to tumor initiation and progression.

• Key Evidence: Research from the Journal of Clinical Oncology highlights that age-related cellular senescence drives increased cancer susceptibility, with a sharp rise in risk observed in individuals aged 60 and above, particularly for colorectal, lung, and prostate cancers.

This review underscores the significant overlap in risk factors and mechanisms between cardiovascular diseases and cancer. Shared determinants such as tobacco use, poor diet, sedentary behavior, alcohol consumption, diabetes, and age highlight opportunities for integrated prevention strategies. 

However, differences in pathophysiological pathways, such as vascular damage in CVD versus tumor-promoting mechanisms in cancer, require tailored interventions. Comprehensive lifestyle modifications and public health initiatives targeting these modifiable factors can substantially reduce the global burden of both diseases. Collaboration between cardiology and oncology disciplines is essential to optimize prevention, research, and care delivery.

References

1.  World Health Organization (WHO) Fact Sheets on Tobacco Use, Alcohol, and Physical Activity.
Available at: https://www.who.int
2.  European Prospective Investigation into Cancer and Nutrition (EPIC) Study.
"Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study."
The Lancet. 2003;361(9368):1496-1501. DOI: 10.1016/S0140-6736(03)13174-1
3.  INTERSALT Study.
"Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24-hour urinary sodium and potassium excretion."
BMJ. 1988;297(6644):319-328. DOI: 10.1136/bmj.297.6644.319
4.  UK Prospective Diabetes Study (UKPDS).
"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes."
Diabetes Care. 1998;21(6):706-719. DOI: 10.2337/diacare.21.6.706
5.  American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention.
"Guidelines on nutrition and physical activity for cancer prevention."
Available at: https://www.cancer.org
6.  American Heart Association (AHA) Guidelines on Cardio-Oncology.
"Cardio-Oncology: Vascular and metabolic perspectives."
Circulation. 2022;146(3). DOI: 10.1161/CIR.0000000000001099
7.  European Society of Cardiology (ESC) Guidelines on Cardiovascular Disease Prevention in Clinical Practice.
"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice."
European Heart Journal. 2021;42(34):3227-3337. DOI: 10.1093/eurheartj/ehab484
8.  ESC Guidelines on Cardio-Oncology.
"2022 ESC Guidelines on cardio-oncology: cardiovascular care of cancer patients and survivors."
European Heart Journal. 2022; 43(41):4029-4113. DOI: 10.1093/eurheartj/ehac244
9.  American Heart Association and American Cancer Society Joint Recommendations.
"Collaborative care for managing cancer patients with cardiovascular complications."
Available at: https://www.heart.org